Skip to main content

Table 8 Comparison between study groups as regards organism clearance after treatment

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

  Group A Group B x2 p value
No growth 27 (84.4%) 8 (25.0%) 20.43 < 0.001**
Resistance 2 (6.3%) 9 (28.1%) 4.952 0.036*
Superinfection 1 (3.1%) 7 (21.9%) 3.571 0048*
Resistance and superinfection 2 (6.3%) 8 (25.0%) 3.721 0.045*
  1. Chi-square test
  2. *Significant
  3. **Highly significant